Have a personal or library account? Click to login
Metformin enhanced in vitro radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5’-monophosphate-activated protein kinase levels in glioblastoma Cover

Metformin enhanced in vitro radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5’-monophosphate-activated protein kinase levels in glioblastoma

Open Access
|Nov 2017

Authors

Sebastian Adeberg

sebastian.adeberg@med.uni-heidelberg.de

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Denise Bernhardt

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Semi B. Harrabi

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Nils H. Nicolay

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Juliane Hörner-Rieber

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Laila König

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Michael Repka

Department of Radiation Medicine, Georgetown University Hospital, Washington DC, USA

Angela Mohr

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Amir Abdollahi

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
Tanslational Radiation Oncology, German Cancer Consortium (DKTK), National Center for Tumor Diseases German Cancer Research Center (DKFZ), Heidelberg, Germany

Klaus-Josef Weber

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Juergen Debus

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Stefan Rieken

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany
Heidelberg Institute for Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
DOI: https://doi.org/10.1515/raon-2017-0042 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 431 - 437
Submitted on: Feb 12, 2017
|
Accepted on: Sep 30, 2017
|
Published on: Nov 1, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Sebastian Adeberg, Denise Bernhardt, Semi B. Harrabi, Nils H. Nicolay, Juliane Hörner-Rieber, Laila König, Michael Repka, Angela Mohr, Amir Abdollahi, Klaus-Josef Weber, Juergen Debus, Stefan Rieken, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.